Lonn S Rider

Title: The Innovative Contributions of Lonn S. Rider

Introduction

Lonn S. Rider, hailing from Foster, Rhode Island, has made significant strides in the field of pharmaceuticals through his inventive mind. With a robust portfolio of 19 patents, Rider has played a pivotal role in advancing opioid synthesis and ensuring the quality and efficacy of pharmaceutical compounds.

Latest Patents

Among his notable innovations, Rider has developed a patent for a "Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone." This invention focuses on creating a composition with minimal levels of impurities, thereby enhancing safety and effectiveness. Another key patent is the "Process for improved opioid synthesis," which encompasses various compounds and methods for producing opioids, including oxycodone. This work assists in the production of active pharmaceutical ingredients (APIs) and their application in treating medical conditions.

Career Highlights

Rider’s career has been marked by his tenure at premier pharmaceutical companies, including Purdue Pharma L.P. and Rhodes Technologies. At these organizations, he has contributed to the development of critical interventions that address pain management and opioid formulations.

Collaborations

Throughout his career, Lonn S. Rider has worked alongside esteemed colleagues such as Qi Hong and Robert Chapman. These collaborations have undoubtedly enriched his work, as they bring together diverse expertise to tackle complex pharmaceutical challenges.

Conclusion

In summary, Lonn S. Rider stands out as a remarkable inventor in the pharmaceutical domain. His innovative patents and collaborative efforts continue to influence the development of safer and more effective opioid formulations, underscoring his important role in the industry.